Medical illustration for Does omeprazole contain soy-derived ingredients or interact with soy foods, posing a risk for people with soy allergy? | Based on NIH - Persly Health Information
Persly Medical TeamPersly Medical Team
February 12, 20265 min read

Does omeprazole contain soy-derived ingredients or interact with soy foods, posing a risk for people with soy allergy? | Based on NIH

Key Takeaway:

Most omeprazole capsules and OTC tablets do not list soy or soy-derived excipients, though inactive ingredients can vary by brand and country. Labels and clinical guidance do not flag soy foods as an interaction; animal data showing increased omeprazole exposure with soybean in rats has not translated to human warnings. People with severe soy allergy should verify the product’s inactive ingredients and consult a pharmacist.

Omeprazole, Soy Ingredients, and Soy Allergy: What You Need to Know

Based on currently available product labels, most omeprazole delayed‑release capsules and OTC tablets do not list soy or soy‑derived excipients (like soy lecithin) among their inactive ingredients. [1] Several representative omeprazole products list excipients such as hypromellose, lactose, mannitol, methacrylic acid copolymers, microcrystalline cellulose, sodium lauryl sulfate, talc, titanium dioxide, triethyl citrate, and gelatin capsule shells with no soy mentioned. [1] Similar ingredient lists appear across multiple manufacturers and OTC omeprazole drug facts, again without any soy‑based components. [2] [3] [4]

That said, excipients can vary by brand, strength, and country, so people with severe soy allergy should verify the specific product’s package insert and consult a pharmacist before use. [1] Some omeprazole capsule labels include sugar spheres, simethicone emulsion, dyes, and other excipients but still do not mention soy. [5] [6] Additional labels list crospovidone, povidone, poloxamer, and coloring agents, without soy‑derived ingredients. [7] Many U.S. DailyMed entries for omeprazole capsules similarly show no soy among inactive ingredients. [8] [9] [10] [11]


Does Omeprazole Interact with Soy Foods?

From a drug–food interaction perspective, standard prescribing information for omeprazole focuses on interactions via stomach pH changes and CYP2C19 metabolism, not soy foods. Typical label drug interaction sections do not list soy or soy foods as a known interaction. [12] [13] These sections emphasize effects on antiretrovirals (such as atazanavir and nelfinavir), antifungals, and other pH‑dependent or CYP2C19‑substrate medicines, and do not mention soy. [14] [15] [16]

Experimental animal data have explored soy’s impact on omeprazole pharmacokinetics: in rats, soybean intake increased omeprazole exposure (higher Cmax and AUC, longer half‑life), which is the opposite of its effect on carbamazepine. [17] While interesting, these findings are from animal studies and are not reflected in human labeling or clinical guidance, so they should be interpreted cautiously and not assumed to represent a clinically significant interaction for people eating soy foods. [17]


Allergy Considerations: Omeprazole vs. Soy

  • Omeprazole can, rarely, cause allergic reactions itself (immediate hypersensitivity such as hives, angioedema, or anaphylaxis), and cross‑reactivity may occur among different proton pump inhibitors (PPIs). [18] Such hypersensitivity is unrelated to soy; it is a reaction to the drug or its class. [19] [20]

  • In documented cases, lansoprazole was sometimes tolerated by individuals allergic to omeprazole, while cross‑reactivity with pantoprazole occurred in some patients. [18] This is useful if someone experiences a PPI allergy, but again, it does not involve soy exposure. [20]


Practical Guidance for People with Soy Allergy

  • Check the exact product label: Inactive ingredients vary. U.S. DailyMed listings for multiple omeprazole capsule and OTC tablet formulations show no soy or soy lecithin among excipients. [1] [7] [8] [5] [6] [2] [3] [4]

  • Ask your pharmacist to confirm the excipient list for the brand and strength you plan to use, especially if your soy allergy is severe. [1]

  • Monitor for any allergic symptoms after starting omeprazole, but remember that documented PPI allergies are not the same as soy allergies and are rare. [18] [19] If you develop hives, swelling, breathing difficulty, or other concerning symptoms, seek medical care and discuss alternative PPIs. [18]


Ingredient Examples from Omeprazole Labels

The following examples illustrate inactive ingredients commonly listed note the absence of soy:

  • Capsule formulations: hypromellose, lactose monohydrate, mannitol, methacrylic acid–ethyl acrylate copolymer, microcrystalline cellulose, mono‑ and diglycerides, polysorbate, sodium lauryl sulfate, talc, titanium dioxide, triethyl citrate; gelatin capsule shells with colorants. [1]

  • Other formulations: anhydrous lactose, cetyl alcohol, disodium hydrogen phosphate dihydrate, hypromellose phthalate, simethicone emulsion, sugar spheres, coloring agents; still no soy listed. [8] [5] [6]

  • OTC tablets (various brands): crospovidone, hypromellose, hypromellose phthalate, mannitol, microcrystalline cellulose, silicon dioxide, sodium stearyl fumarate, sucralose, talc, titanium dioxide, triethyl citrate; no soy. [2] [3] [4]


Bottom Line

  • Most omeprazole products do not list soy or soy‑derived excipients, and standard interaction guidance does not flag soy foods as a clinically relevant interaction. [1] [2] [3] [4] [12] [13]

  • Animal data suggest soybean can increase omeprazole exposure in rats, but this has not translated into human warnings or routine clinical advice. [17]

  • If you have a severe soy allergy, it’s reasonable to verify the specific product’s inactive ingredients and consult a pharmacist. [1]


References

  • Representative DailyMed ingredient listings for omeprazole capsules and OTC tablets without soy excipients. [1] [7] [8] [9] [5] [10] [11] [6] [2] [3] [4]

  • Omeprazole drug interaction sections focusing on CYP2C19 and pH‑dependent drugs; no soy interactions listed. [12] [21] [14] [15] [13] [16]

  • Animal study: soybean administration increased omeprazole exposure in rats. [17]

  • Case reports/reviews: immediate hypersensitivity to PPIs and cross‑reactivity patterns. [18] [19] [20] [22]

Related Questions

Related Articles

Sources

  1. 1.^abcdefghiDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  2. 2.^abcdeBJWC Omeprazole Drug Facts(dailymed.nlm.nih.gov)
  3. 3.^abcdeAmazon Omeprazole Drug Facts(dailymed.nlm.nih.gov)
  4. 4.^abcdeOMEPRAZOLE tablet, orally disintegrating, delayed release(dailymed.nlm.nih.gov)
  5. 5.^abcdDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  6. 6.^abcdDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  7. 7.^abcOmeprazole DR Capsules These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE CAPSULES. OMEPRAZOLE delayed-release capsules, for oral use INITIAL U.S. APPROVAL: 1989(dailymed.nlm.nih.gov)
  8. 8.^abcdThese highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE CAPSULES. OMEPRAZOLE delayed-release capsules, for oral use Initial U.S. Approval: 1989(dailymed.nlm.nih.gov)
  9. 9.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  10. 10.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  11. 11.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  12. 12.^abcDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  13. 13.^abcDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  14. 14.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  15. 15.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  16. 16.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  17. 17.^abcdEffect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats.(pubmed.ncbi.nlm.nih.gov)
  18. 18.^abcdeNine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors.(pubmed.ncbi.nlm.nih.gov)
  19. 19.^abc[Hypersensitivity to proton pump inhibitors].(pubmed.ncbi.nlm.nih.gov)
  20. 20.^abcStudy of cross-reactivity between proton pump inhibitors.(pubmed.ncbi.nlm.nih.gov)
  21. 21.^DailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
  22. 22.^Study of cross-reactivity between proton pump inhibitors.(pubmed.ncbi.nlm.nih.gov)

Important Notice: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any medical decisions.